RESEARCH-USE BIOSIMILAR ANTIBODY
Ongericimab
Monoclonal antibody · IgG4
Ongericimab (JS002) is a humanized anti-PCSK9 monoclonal antibody. Ongericimab has lipid-lowering efficacy. Ongericimab can be used in research of hypercholesteremia and hyperlipidemia.
TARGETPCSK9
YMonoclonal antibody
CATALOGSC-BS-320
CATALOG NUMBERSC-BS-320
MOLECULAR WEIGHTApprox. 143.02 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ongericimab (JS002) is a humanized anti-PCSK9 monoclonal antibody. Ongericimab has lipid-lowering efficacy. Ongericimab can be used in research of hypercholesteremia and hyperlipidemia.
Ongericimab is a recombinant research-use antibody directed against PCSK9.